Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Neogen Corporation    NEOG

NEOGEN CORPORATION

(NEOG)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Neogen : launches portable version of its Raptor® system

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/01/2019 | 03:17pm EDT

LANSING, Mich., April 1, 2019 - Neogen has introduced a portable version of its innovative Raptor® Integrated Analysis Platform that provides the option of performing mycotoxin testing in the laboratory - or wherever a tester may choose.

Neogen's new Raptor Solo is a battery-operated portable version of the company's popular Raptor Integrated Analysis Platform. As with the original benchtop version, the new Raptor is a lateral flow test strip reader with built-in incubation that provides an easy way to objectively analyze and store results of Neogen's Reveal® Q+ MAX lateral flow tests.

'The addition of Raptor Solo provides the option of performing testing for mycotoxins wherever works best for you, whether that's in a traditional lab setting, or anywhere else,' said Neogen's Mary Gadola. 'We've developed the new Raptor Solo as a single-port unit utilizing the same technology as the larger three-port Raptor system.'

The Raptor systems control the timing, temperature and reading of the test strips, allowing testers to simply add sample and walk away. They also protect the integrity and consistency of testing data by processing and analyzing results without additional operator input.

Raptor's features and benefits include:

  • Barcoded test strips to identify the test type, lot and expiry
  • The ability to just add sample and walk away
  • Its system controls test parameters for data integrity
  • Connectivity options for easy testing data transfer, including Wi-Fi or USB
  • The use of Neogen Data Manager Software system for easy data analysis

Neogen offers the most comprehensive range of food safety diagnostic test products for foodborne bacteria, mycotoxins, drugs, allergens, and other concerns. Its full line of mycotoxin test kits detect aflatoxin, aflatoxin M1, deoxynivalenol (DON), fumonisin, ochratoxin, T-2/HT-2, and zearalenone.

Neogen Corporation (NASDAQ: NEOG) develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in worldwide biosecurity products, animal genomics testing and the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals and veterinary instruments.

This press release is also available in: [ PRINTABLE VERSION ][ PORTUGUESE ] [ SPANISH ]

Disclaimer

Neogen Corporation published this content on 01 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 01 April 2019 19:16:13 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NEOGEN CORPORATION
04/11NEOGEN : reg; Viroxide Super receives DEFRA Approval for Diseases of Poultry Ord..
PU
04/01NEOGEN : launches portable version of its Raptor® system
PU
03/29NEOGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
03/26NEOGEN CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
03/26NEOGEN : Fiscal 3Q Earnings Snapshot
AQ
03/26NEOGEN : reports third quarter results
PR
03/25NEOGEN : launches coconut food allergen test kits
PR
03/18NEOGEN : reg; Viroxide Super proven effective against African Swine Fever
PU
03/04NEOGEN : Viroxide Super broad spectrum disinfectant launched
PU
02/25NEOGEN : Scottish Government extends genomics partnership with Neogen
PU
More news
Financials ($)
Sales 2019 414 M
EBIT 2019 67,4 M
Net income 2019 59,3 M
Finance 2019 0,28 M
Yield 2019 -
P/E ratio 2019 51,24
P/E ratio 2020 46,93
Capi. / Sales 2019 7,25x
Capi. / Sales 2020 6,76x
Capitalization 3 004 M
Chart NEOGEN CORPORATION
Duration : Period :
Neogen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOGEN CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 63,5 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
John E. Adent President & Chief Executive Officer
James Lamar Herbert Executive Chairman & Director-Strategic Growth
Steven James Quinlan Chief Financial Officer, Secretary & VP
Mark A. Mozola Vice President-Research & Development
Joseph M. Madden Vice President-Scientific Affairs
Sector and Competitors
1st jan.Capitalization (M$)
NEOGEN CORPORATION1.12%3 004
MEDTRONIC PLC-5.85%114 132
BAXTER INTERNATIONAL INC.15.89%39 019
HOYA CORPORATION17.39%25 740
ZIMMER BIOMET HOLDINGS19.99%25 114
ALIGN TECHNOLOGY41.85%23 685